Athersys
ATHX
#10565
Rank
ยฃ0.62 M
Marketcap
ยฃ0.01013
Share price
-33.50%
Change (1 day)
-98.95%
Change (1 year)

Revenue for Athersys (ATHX)

Revenue in 2023 (TTM): ยฃ0.06 Million

According to Athersys's latest financial reports the company's current revenue (TTM ) is ยฃ0.06 Million. In 2022 the company made a revenue of ยฃ4.4 Million an increase over the revenue in the year 2021 that were of ยฃ4.08 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Athersys from 2007 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ0.06 M-98.54%
2022 ยฃ4.4 M7.73%
2021 ยฃ4.08 M288.83%
2020 ยฃ1.05 M-75.03%
2019 ยฃ4.2 M-77.5%
2018 ยฃ18.7 M788.96%
2017 ยฃ2.1 M-84.02%
2016 ยฃ13.15 M89.38%
2015 ยฃ6.94 M3682.89%
2014 ยฃ0.18 M-59.87%
2013 ยฃ0.45 M-88.29%
2012 ยฃ3.9 M-41.27%
2011 ยฃ6.65 M14.93%
2010 ยฃ5.79 M334.01%
2009 ยฃ1.33 M-37.02%
2008 ยฃ2.11 M29.1%
2007 ยฃ1.64 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ27.00 B 44,963,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 78,482,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.05 B 60,042,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
ยฃ1.65 B 2,752,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 B 115,186,150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
ยฃ0.27 B 455,961.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
ยฃ0.27 M 366.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.21 B 80,293,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.67 B 59,406,251.25%๐Ÿ‡ซ๐Ÿ‡ท France